Dalgleish AG - Search Results

1

Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.

Pandha HS, John RJ, Hutchinson J, James N, Whelan M, Corbishley C, Dalgleish AG. Pandha HS, et al. Among authors: dalgleish ag. BJU Int. 2004 Aug;94(3):412-8. doi: 10.1111/j.1464-410X.2004.04922.x. BJU Int. 2004. PMID: 15291878 Clinical Trial.

2

Advances in prostate cancer immunotherapy.

Havranek EG, Whelan MA, Greenhalgh R, Dalgleish AG, Pandha H. Havranek EG, et al. Among authors: dalgleish ag. Surg Oncol. 2002 Jun;11(1-2):35-45. doi: 10.1016/s0960-7404(02)00012-9. Surg Oncol. 2002. PMID: 12031866 Review.

3

Cryopreservation of immature monocyte-derived dendritic cells results in enhanced cell maturation but reduced endocytic activity and efficiency of adenoviral transduction.

John J, Hutchinson J, Dalgleish A, Pandha H. John J, et al. J Immunol Methods. 2003 Jan 15;272(1-2):35-48. doi: 10.1016/s0022-1759(02)00430-1. J Immunol Methods. 2003. PMID: 12505710

4

Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination.

John J, Dalgleish A, Melcher A, Pandha H. John J, et al. J Immunol Methods. 2005 Apr;299(1-2):37-46. doi: 10.1016/j.jim.2004.12.014. Epub 2005 Jan 28. J Immunol Methods. 2005. PMID: 15890354

5

Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapy.

Pandha HS, Cook D, Greenhalgh R, Dalgleish A. Pandha HS, et al. BJU Int. 2005 Jun;95(9):1336-43. doi: 10.1111/j.1464-410X.2005.05528.x. BJU Int. 2005. PMID: 15892827

6

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity.

Todryk SM, Eaton J, Birchall L, Greenhalgh R, Soars D, Dalgleish AG, Melcher AA, Pandha HS. Todryk SM, et al. Among authors: dalgleish ag. Cancer Immunol Immunother. 2004 Apr;53(4):323-30. doi: 10.1007/s00262-003-0452-1. Epub 2003 Nov 28. Cancer Immunol Immunother. 2004. PMID: 14648067 Free PMC article.

7

Oncological applications of gene therapy.

Pandha HS, Martin LA, Rigg AS, Ross P, Dalgleish AG. Pandha HS, et al. Among authors: dalgleish ag. Curr Opin Investig Drugs. 2000 Sep;1(1):122-34. Curr Opin Investig Drugs. 2000. PMID: 11249588 Review.

8

Detection of T cell cytokine production as a tool for monitoring immunotherapy.

John J, Pandha H, Dalgleish AG. John J, et al. Among authors: dalgleish ag. Dis Markers. 2000;16(1-2):71-5. doi: 10.1155/2000/163267. Dis Markers. 2000. PMID: 11360831 Free PMC article. Review. No abstract available.

9

Cancer vaccines as a therapeutic modality: The long trek.

Dalgleish AG, Whelan MA. Dalgleish AG, et al. Cancer Immunol Immunother. 2006 Aug;55(8):1025-32. doi: 10.1007/s00262-006-0128-8. Epub 2006 Feb 28. Cancer Immunol Immunother. 2006. PMID: 16506069 Free PMC article. Review.

10

Immunotherapeutic potential of whole tumour cells.

Ward S, Casey D, Labarthe MC, Whelan M, Dalgleish A, Pandha H, Todryk S. Ward S, et al. Cancer Immunol Immunother. 2002 Sep;51(7):351-7. doi: 10.1007/s00262-002-0286-2. Epub 2002 Jun 14. Cancer Immunol Immunother. 2002. PMID: 12192534 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters